Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity.
about
Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@en
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@nl
type
label
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@en
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@nl
prefLabel
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@en
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@nl
P2093
P2860
P356
P1433
P1476
Celecoxib targets breast cance ...... ting the Wnt pathway activity.
@en
P2093
Changjiang Huang
Chaolin Huang
Junping Zhao
Qiaoxiang Dong
Xuejing Song
Yongping Wang
Yuanhong Chen
P2860
P304
115254-115269
P356
10.18632/ONCOTARGET.23250
P407
P577
2017-12-14T00:00:00Z